admin

$100 / 3 Month Trial “Gold Light” Membership Level Gold Level Access | TrendSpider or TradingSim Not Included 15 Minute Live-Stream Alert List! (we hate spam too) Bob’s 5 Most Powerful Video Tutorial – Free 14 Day Free Trial Final Days! Hurry! One To One Coaching Sessions ================================================= Partner Discounts TrendSpider Automated Charting Tour Use
0 Comments
After an incredible run-up in the days after its initial public offering, volatility in Robinhood (NASDAQ:HOOD) is mostly absent. That did not stop the bearish selling on HOOD stock from accelerating after the company posted quarterly results on Oct. 26. Source: OpturaDesign / Shutterstock.com Robinhood fell after posting third-quarter results. What did investors not like?
0 Comments
In this article MAXR A close look at the primary mirror of a Worldview Legion satellite during assembly and inspection. Maxar Maxar Technologies‘ stock jumped on Thursday after reporting third-quarter results, with Wall Street analysts welcoming the space company’s progress toward the launch of key satellites next year. The company reported an adjusted EBITDA profit
0 Comments
It has been an excellent third-quarter earnings season so far. Of the S&P 500 stocks that have reported earnings, a majority have beaten analyst estimates.  According to Factset Insight, 56% of the index companies have reported earnings so far in Q3 2021. Of those, 82% beat the consensus earnings per share (EPS). That’s higher than
0 Comments
Over the trailing year, a majority of my single-company opinions have been at least middle of the road for obvious reasons. Although I do have broader economic concerns, benchmark indices have proven resilient. So, my headline to consider exiting Novavax (NASDAQ:NVAX) stock might seem controversial. Source: Ascannio/Shutterstock.com However, I genuinely believe taking the green ink
0 Comments
Crisis often means opportunity when it comes to stocks. Echoing Warren Buffett, when there’s widespread uncertainty, it often means it’s a good time to buy. Many high-quality stocks that had nothing to do with Brexit got pummeled in the wake of the UK vote to leave the European Union. They are worth considering — even as
0 Comments
Big Oil has been out of favor for over a decade. But on the reopen, are the analysts finally bullish? Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
If you’ve read my prior articles on Ocugen (NASDAQ:OCGN), you know full well my heavily bearish view about OCGN stock. What’s the story here? The company is trying to bring Covaxin, a Covid-19 vaccine candidate developed by India’s Bharat Biotech, to the U.S. and Canada. Source: shutterstock.com/PhotobyTawat So far, it’s made little progress obtaining Emergency
0 Comments
In this article PFE CNBC’s Jim Cramer on Friday took comfort in a prediction by Dr. Scott Gottlieb that the pandemic phase of Covid could be over by January. “Dr. Gottlieb basically said the war’s over, and that’s just incredible,” Cramer said. Gottlieb, who had served as FDA chief under former President Donald Trump, is
0 Comments